Article Details

Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag)

Retrieved on: 2023-12-15 19:09:32

Tags for this article:

Click the tags to see associated articles and topics

Oncology Drug Crash Course: Nivolumab Plus Relatlimab (Opdualag). View article details on hiswai:

Excerpt

Immune checkpoint inhibitors such as nivolumab-relatlimab help restimulate the immune system, particularly the T cells, via various mechanisms. 1.

Article found on: www.oncnursingnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo